EGFR and neoplasm: The frequency of smokers 0 pack-years (68.8%, 53/77) among patients with tumours having EGFR mutations was significantly higher than that among smokers 0–30 pack-years (50.0%) and smokers ≥30 pack-years (0.0%) (P<0.001) (Table 2).